HbO2 Therapeutics

Overview
Animal Therapeutics?
Product stageSegments
Seed
?
Next-generation vaccines and drugs
?

HbO2 Therapeutics develops and manufactures oxygen-carrying solutions, a class of drug products that when administered intravenously can increase the amount of oxygen transported throughout the body. It offers two products. Hemopure [hemoglobin glutamer – 250 (bovine)], for use in humans, and Oxyglobin [hemoglobin glutamer – 200 (bovine)]) for veterinary use. The company was founded in 2014 and is headquartered in Souderton, Pennsylvania.

HQ location:
674 Souder Road Souderton PA USA
Founded year:
2014
Employees:
1-10
IPO status:
Private
Total funding:
USD 2.8 mn
Last Funding:
USD 150.0 k (Seed; Apr 2015)
Last valuation:
-
Key competitors
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...

EDGE Insights

Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.